NPI: 1811257108 · LANCASTER, PA 17601 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 05/21/2012
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 05/21/2012 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 17,871 | $23K |
| 2019 | 18,077 | $12K |
| 2020 | 5,483 | $293K |
| 2021 | 11,976 | $862K |
| 2022 | 6,867 | $593K |
| 2023 | 4,790 | $488K |
| 2024 | 3,795 | $412K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 32,399 | 2,779 | $2.64M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 15,920 | 985 | $37K |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 546 | 290 | $3K |
| 85041 | 1,261 | 1,155 | $0.00 | |
| J1756 | Injection, iron sucrose, 1 mg | 2,197 | 639 | $0.00 |
| 83540 | 849 | 808 | $0.00 | |
| 83970 | 984 | 818 | $0.00 | |
| 85048 | 1,274 | 1,154 | $0.00 | |
| 82947 | 40 | 38 | $0.00 | |
| 82108 | 61 | 60 | $0.00 | |
| A4657 | Syringe, with or without needle, each | 3,641 | 1,867 | $0.00 |
| 83550 | 830 | 788 | $0.00 | |
| 82728 | 690 | 664 | $0.00 | |
| J1270 | Injection, doxercalciferol, 1 mcg | 7,767 | 717 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 28 | 27 | $0.00 |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 209 | 149 | $0.00 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 16 | 15 | $0.00 |
| 90674 | 20 | 19 | $0.00 | |
| 82607 | 66 | 64 | $0.00 | |
| 82746 | 61 | 60 | $0.00 |